Feed Preview

Fast Growing

Cardiovascular Biology of GLP-1

Cardiovascular Biology of GLP-1 diagram by ibreakstock, Shutterstock
ibreakstock, Shutterstock

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Top 20 most recent papers
The Lancet. Diabetes & Endocrinology

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

The Lancet. Diabetes & EndocrinologyJanuary 12, 2020
Hertzel C GersteinTheodora Temelkova-Kurktschiev
27
1
bioRxiv

Bariatric surgery reveals a gut-restricted TGR5 agonist that exhibits anti-diabetic effects

bioRxivJanuary 11, 2020
Snehal N. ChaudhariA. Sloan Devlin
18
Scientific Reports

The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids

Scientific ReportsJanuary 15, 2020
Sarah DucastelSophie Lestavel
3
Diabetes Care

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

Diabetes CareJanuary 18, 2020
Natasha C BergmannFilip K Knop
6
Endocrine-related Cancer

Innovative imaging of insulinoma: the end of sampling? A review

Endocrine-related CancerJanuary 18, 2020
Emanuel ChristDamian Wild
Diabetes & Metabolism

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: an updated systematic review of randomized controlled trials

Diabetes & MetabolismJanuary 11, 2020
Alessandro MantovaniGiovanni Targher
1
Bone

Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity

BoneJanuary 19, 2020
Rasmus Fuglsang-NielsenJakob Starup-Linde
Diabetes, Obesity & Metabolism

Comparison of two glucagon-like-peptide-1 analogs (GLP -1) dulaglutide vs liraglutide for the management of diabetes in solid organ transplant (SOT): a retrospective study

Diabetes, Obesity & MetabolismJanuary 17, 2020
Priyamvada SinghShumei Meng
8
Diabetes, Obesity & Metabolism

Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice. The case of GLP-1 receptor agonists

Diabetes, Obesity & MetabolismJanuary 17, 2020
Veronica SciannameoDARWIN-T2D study
10
Diabetes/metabolism Research and Reviews

Efficacy of Exenatide and Insulin Glargine on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Diabetes/metabolism Research and ReviewsJanuary 20, 2020
Lin LiuXin Gao
Diabetes, Obesity & Metabolism

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL

Diabetes, Obesity & MetabolismJanuary 9, 2020
Nienke M A IdzerdaHiddo J L Heerspink
Nature

Activation of the GLP-1 receptor by a non-peptidic agonist

NatureJanuary 10, 2020
Peishen ZhaoDenise Wootten
119
1
1
1
Journal of Molecular Biology

The role of α-cells in islet function and glucose homeostasis in health and type 2 diabetes

Journal of Molecular BiologyJanuary 19, 2020
Patrick Gilon
Journal of Molecular Endocrinology

Glutamine-induced signaling pathways via amino acid receptors in enteroendocrine L cell line

Journal of Molecular EndocrinologyJanuary 16, 2020
Takumi NakamuraTakashi Tsuboi
1
Cardiovascular Endocrinology & Metabolism

Cardioprotective diabetes drugs: what cardiologists need to know

Cardiovascular Endocrinology & MetabolismJanuary 17, 2020
Jenifer M Brown, Brendan M Everett
1
Progress in Neuro-psychopharmacology & Biological Psychiatry

The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder

Progress in Neuro-psychopharmacology & Biological PsychiatryJanuary 20, 2020
Adriano José Maia Chaves FilhoDanielle S Macedo
Nutrients

Policaptil Gel Retard Intake Reduces Postprandial Triglycerides, Ghrelin and Appetite in Obese Children: A Clinical Trial

NutrientsJanuary 18, 2020
Elena FornariClaudio Maffeis
Journal of Diabetes and Its Complications

Oral semaglutide in type 2 diabetes

Journal of Diabetes and Its ComplicationsJanuary 19, 2020
Sarah L AndersonJennifer M Trujillo
1
Stem Cells International

GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice

Stem Cells InternationalJanuary 18, 2020
Ying ChangNingyi Jin
Biochemical and Biophysical Research Communications

Liraglutide promotes the angiogenic ability of human umbilical vein endothelial cells through the JAK2/STAT3 signaling pathway

Biochemical and Biophysical Research CommunicationsJanuary 18, 2020
Yanbo DiYong Liu

See more papers from this feed

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2020 Meta ULC. All rights reserved
/feed-previews/cardiovascular-biology-of-glp-1/0a5b9dc0-b6b2-4990-9d5f-dbd4b337b802